Life-extending prostate drug is ruled out for NHS use as officials deem it's not worth the money 

The National Institute for Health and Care Excellence (Nice) said evidence on the benefits of olaparib is uncertain and approving it would not be a good use of NHS funds.

from Health News | Mail Online https://ift.tt/3JGiMYm

Comments

Popular posts from this blog

Man hit with $650K medical bill for emergency back surgery gets relief